Literature DB >> 22270365

Contradictory functions (activation/termination) of neutrophil proteinase 3 enzyme (PR3) in interleukin-33 biological activity.

Suyoung Bae1, Taebong Kang, Jaewoo Hong, Siyoung Lee, Jida Choi, Hyunjhung Jhun, Areum Kwak, Kwangwon Hong, Eunsom Kim, Seunghyun Jo, Soohyun Kim.   

Abstract

IL-1 family ligand does not possess a typical hydrophobic signal peptide and needs a processing enzyme for maturation. The maturation process of IL-33 (IL-1F11), a new member of the IL-1 family ligand, remains unclear. Precursor IL-33 ligand affinity column isolates neutrophil proteinase 3 (PR3) from human urinary proteins. PR3 is a known IL-1 family ligand-processing enzyme for IL-1β (IL-1F2) and IL-18 (IL-1F4), including other inflammatory cytokines. We investigated PR3 in the maturation process of precursor IL-33 because we isolated urinary PR3 by using the precursor IL-33 ligand affinity column. PR3 converted inactive human and mouse precursor IL-33 proteins to biological active forms; however, the increase of PR3 incubation time abrogated IL-33 activities. Unlike caspase-1-cleaved precursor IL-18, PR3 cut precursor IL-33 and IL-18 at various sites and yielded multibands. The increased incubation period of PR3 abated mature IL-33 in a time-dependent manner. The result is consistent with the decreased bioactivity of IL-33 along with the increased PR3 incubation time. Six different human and mouse recombinant IL-33 proteins were expressed by the predicted consensus amino acid sequence of PR3 cleavage sites and tested for bioactivities. The human IL-33/p1 was highly active, but human IL-33/p2 and p3 proteins were inactive. Our results suggest the dual functions (activation/termination) of PR3 in IL-33 biological activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270365      PMCID: PMC3318695          DOI: 10.1074/jbc.M111.295055

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1.

Authors:  Corinne Cayrol; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-13       Impact factor: 11.205

2.  IL-33 raises alarm.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

3.  IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells.

Authors:  Liying Guo; Gang Wei; Jinfang Zhu; Wei Liao; Warren J Leonard; Keji Zhao; William Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-29       Impact factor: 11.205

4.  Mature interleukin-33 is produced by calpain-mediated cleavage in vivo.

Authors:  Morisada Hayakawa; Hiroko Hayakawa; Yasushi Matsuyama; Hiroyuki Tamemoto; Hitoaki Okazaki; Shin-ichi Tominaga
Journal:  Biochem Biophys Res Commun       Date:  2009-07-09       Impact factor: 3.575

5.  Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

Authors:  Tatjana Pecaric-Petkovic; Svetlana A Didichenko; Sacha Kaempfer; Nicole Spiegl; Clemens A Dahinden
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

6.  Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils.

Authors:  Maho Suzukawa; Rikiya Koketsu; Motoyasu Iikura; Susumu Nakae; Kenji Matsumoto; Hiroyuki Nagase; Hirohisa Saito; Kouji Matsushima; Ken Ohta; Kazuhiko Yamamoto; Masao Yamaguchi
Journal:  Lab Invest       Date:  2008-09-01       Impact factor: 5.662

7.  An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor.

Authors:  Maho Suzukawa; Motoyasu Iikura; Rikiya Koketsu; Hiroyuki Nagase; Chise Tamura; Akiko Komiya; Susumu Nakae; Kouji Matsushima; Ken Ohta; Kazuhiko Yamamoto; Masao Yamaguchi
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

8.  IL-33-activated dendritic cells induce an atypical TH2-type response.

Authors:  Matthew A Rank; Takao Kobayashi; Hideaki Kozaki; Kathleen R Bartemes; Diane L Squillace; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2009-04-10       Impact factor: 10.793

9.  CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation.

Authors:  Zoulfia Allakhverdi; Michael R Comeau; Dirk E Smith; Dean Toy; Leandra Mfuna Endam; Martin Desrosiers; Yong-Jun Liu; Karen J Howie; Judah A Denburg; Gail M Gauvreau; Guy Delespesse
Journal:  J Allergy Clin Immunol       Date:  2008-12-06       Impact factor: 10.793

10.  Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

Authors:  Alexander U Lüthi; Sean P Cullen; Edel A McNeela; Patrick J Duriez; Inna S Afonina; Clare Sheridan; Gabriela Brumatti; Rebecca C Taylor; Kristof Kersse; Peter Vandenabeele; Ed C Lavelle; Seamus J Martin
Journal:  Immunity       Date:  2009-06-25       Impact factor: 31.745

View more
  28 in total

1.  Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33.

Authors:  Ying Lai; William A Altemeier; John Vandree; Adrian M Piliponsky; Brian Johnson; Cara L Appel; Charles W Frevert; Dallas M Hyde; Steven F Ziegler; Dirk E Smith; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  J Allergy Clin Immunol       Date:  2013-11-09       Impact factor: 10.793

2.  The inhibitory function of Fc-ST2 depends on cell type; IL-1RAcP and ST2 are necessary but insufficient for IL-33 activity.

Authors:  Kwangwon Hong; Youngmin Lee; Siyoung Lee; Sungnoh Hong; Suyoung Bae; Jaewoo Hong; Jida Choi; Hyunjhung Jhun; Areum Kwak; Eunsom Kim; Seunghyun Jo; Taebong Kang; You Sook Cho; Yong-Gil Kim; Soohyun Kim
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

Review 3.  Interleukin-33 in health and disease.

Authors:  Foo Yew Liew; Jean-Philippe Girard; Heth Roderick Turnquist
Journal:  Nat Rev Immunol       Date:  2016-09-19       Impact factor: 53.106

Review 4.  IL-33 and the intestine: The good, the bad, and the inflammatory.

Authors:  Zerina Hodzic; Ellen Merrick Schill; Alexa M Bolock; Misty Good
Journal:  Cytokine       Date:  2017-07-04       Impact factor: 3.861

Review 5.  IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.

Authors:  Dov B Ballak; Rinke Stienstra; Cees J Tack; Charles A Dinarello; Janna A van Diepen
Journal:  Cytokine       Date:  2015-07-17       Impact factor: 3.861

6.  Interleukin (IL)-33 immunobiology in asthma and airway inflammatory diseases.

Authors:  Rohit Gaurav; Jill A Poole
Journal:  J Asthma       Date:  2021-12-27

7.  Structural insights into the interaction of IL-33 with its receptors.

Authors:  Xi Liu; Michal Hammel; Yanfeng He; John A Tainer; U-Ser Jeng; Linqi Zhang; Shuying Wang; Xinquan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

8.  Interleukin-33 and ST2 Signaling in Tumor Microenvironment.

Authors:  Jaewoo Hong; Soohyun Kim; P Charles Lin
Journal:  J Interferon Cytokine Res       Date:  2018-09-25       Impact factor: 2.607

9.  Deubiquitination and stabilization of IL-33 by USP21.

Authors:  Lianqin Tao; Chen Chen; Huihui Song; Miranda Piccioni; Guochao Shi; Bin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

10.  Proteinase 3 Induces Neuronal Cell Death Through Microglial Activation.

Authors:  Kyu Suk Cho; Eun Joo Lee; Jung Nam Kim; Ji Woong Choi; Hahn Young Kim; Seol-Heui Han; Jong Hoon Ryu; Jae Hoon Cheong; Chan Young Shin; Kyoung Ja Kwon
Journal:  Neurochem Res       Date:  2015-09-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.